Tag: Chip designer

Browse our exclusive articles!

British chip designer Arm secures $52.3bn valuation in highly anticipated IPO on Nasdaq

Arm achieves $52.3B valuation in highly anticipated IPO, becoming Britain's most successful tech company and a leader in chip design.

Arm Holdings Raises $4.87B in Year’s Largest IPO, Boosting Global Equity Markets, UK

Arm Holdings' $4.87 billion IPO success could boost tech start-ups and equity markets, as SoftBank retains 90% of shares. Watch its Nasdaq debut!

Arm’s IPO Sees Strong Investor Demand, Valuation Climbs to $54.5B

Arm's IPO garners strong investor demand, achieving a valuation of $54.5 billion. The chip designer aims to expand beyond mobile and capitalize on growth opportunities in cloud computing and automotive sectors.

Nvidia Partners with Tata Group and Reliance Industries to Transform India with AI Technology

Nvidia partners with Tata Group and Reliance Industries to drive AI transformation in India, creating opportunities and technological advancements.

Arm Holdings Seeks to Raise $4.87B in IPO, Attracting Tech Giants Like Apple and Google, UK

Arm Holdings aims to raise $4.87 billion in its IPO, backed by tech giants like Apple and Google. The semiconductor unit of SoftBank plans to list on Nasdaq with a valuation of $54.5 billion.

Popular

Tech Evolution: From Obama’s Optimism to Harris’s Vision

Explore the evolution of tech policy from Obama's optimism to Harris's vision at the Democratic National Convention. What's next for Democrats in tech?

Tonix Pharmaceuticals TNXP Shares Fall 14.61% After Q2 Earnings Report

Tonix Pharmaceuticals TNXP shares decline 14.61% post-Q2 earnings report. Evaluate investment strategy based on company updates and market dynamics.

The Future of Good Jobs: Why College Degrees are Essential through 2031

Discover the future of good jobs through 2031 and why college degrees are essential. Learn more about job projections and AI's influence.

Pioneering Research Uncovers Vital Biomarker for Orbital Inflammation

An in-depth study reveals HLF as a potential biomarker for orbital inflammation, offering new insights for diagnosis and treatment strategies.

Subscribe

spot_imgspot_img